Lexeo Therapeutics (LXEO) Live Share Price, Invest From India

Lexeo Therapeutics Stock Performance

as on December 9, 2025 at 1:37 am IST

Day's Low
Day's High
$9.25
Day's Price Range
$9.71
$9.46
2.22%
Downside
2.64%
Upside
52 Week's Low
52 Week's High
$1.45
52-Week Price Range
$10.38
$9.46
84.67%
Downside
9.73%
Upside

Lexeo Therapeutics share price movements today

Previous Close: $9.35
Open: $9.44
Volume: 559.3K
Day's Low - High: $9.25 - $9.71
52 Week Low - High: $1.45 - $10.38

Lexeo Therapeutics Historical Returns

1 Month Return: + 14.16 %
3 Month Return: + 78.1 %
1 Year Return: + 22.54 %
3 Year Return: 0 %
5 Year Return: 0 %

Lexeo Therapeutics Stock Fundamentals & Key Indicators

Check Lexeo Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$682.4M

EPS (TTM)

-1.9343

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-6.48

Industry PE ratio

PEG Ratio

EBITDA

-112.9M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-80.69%

Lexeo Therapeutics Stock Valuation

Track how Lexeo Therapeutics P/E has moved over time to understand its valuation trends.

Lexeo Therapeutics in the last 5 years

Overview
Trends

Lowest (-3.79x)

September 30, 2024

Industry (0.00x)

December 8, 2025

Today (-6.48x)

December 8, 2025

Highest (-0.94x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -6.48x

Lexeo Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lexeo Therapeutics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Lexeo Therapeutics	BUY	$682.4M	NA	-6.48	0.00%
Insmed Incorporated	BUY	$43.5B	418.42%	-16.34	-264.83%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	257.77%	1431.62	1.36%
Vertex Pharmaceuticals Incorporated	BUY	$116.8B	98.18%	32.05	31.35%
Regeneron Pharmaceuticals, Inc.	BUY	$76.1B	44.5%	17.21	32.13%

Stock Returns calculator for Lexeo Therapeutics Stock including INR - Dollar returns

The Lexeo Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Lexeo Therapeutics investment value today

Current value as on today

₹1,30,123

Returns

₹30,123

(+30.12%)

Returns from Lexeo Therapeutics Stock

₹23,984 (+23.98%)

Dollar Returns*

₹6,139 (+6.14%)

Analyst Recommendation on Lexeo Therapeutics Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Lexeo Therapeutics. Average target price of $19.4

Lexeo Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Lexeo Therapeutics.

What analysts predicted

51.24%UPSIDE

Target Price

$19.4

Current Price

$9.46

Analyzed by

11 Analysts

Target

$19.40

Lexeo Therapeutics target price $19.4, a slight upside of 51.24% compared to current price of $9.46. According to 11 analysts rating.

Lexeo Therapeutics Stock’s Investor Sentiment and Interest

Search interest for Lexeo Therapeutics Stock has decreased by -68% in the last 30 days, reflecting a downward trend in search activity.

Time period: November 9, 2025 to December 9, 2025

Change:-68% versus previous 30 day period

Lexeo Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	-	-	-	-	-	-	1	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-13	-20	-14	-23	-23	-31	-27	-33	-30	-21
EBITDA	-12	-19	-13	-21	-20	-28	-25	-32	-25	-19
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-13	-20	-14	-21	-21	-29	-25	-32	-26	-20
Income Tax Expense	0	0	0	0	-	-	-	-	-	-
Net Income	-13	-20	-14	-21	-21	-29	-25	-32	-26	-20
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-1333.54%	0.00%	0.00%	0.00%

Lexeo Therapeutics Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	1	0	-	-
Gross Profit	0	1	0	-1	-2
Operating Income	-4	-50	-60	-68	-105
EBITDA	-4	-50	-58	-64	-96
Interest Expense	0	-	0	0	0
Depreciation	-	0	1	1	2
Income Before Tax	-5	-50	-59	-66	-98
Income Tax Expense	0	0	0	0	-
Net Income	-5	-50	-59	-66	-98
Net Profit Margin	-993.83%	-3055.04%	-9063.76%	0.00%	0.00%

Lexeo Therapeutics Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-20	-14	-21	-21	-29	-25	-32	-26	-20
Operating Cash Flow	-13	-13	-14	-20	-17	-28	-21	-27	-29
Investing Cash Flow	0	0	0	0	0	-93	15	-39	35
Financing Cash Flow	3	100	88	0	0	0	0	72	0
Change in Cash	-10	86	73	-20	-17	-122	-6	6	5

Lexeo Therapeutics Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-50	-59	-66	-98
Operating Cash Flow	-44	-54	-59	-81
Investing Cash Flow	0	0	0	-94
Financing Cash Flow	150	0	103	88
Change in Cash	106	-55	44	-86

Insights on Lexeo Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 3 months, LXEO stock has moved up by 78.1%
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -32.65M → -20.28M (in $), with an average increase of 26.9% per quarter
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 37.0K → 1.94M (in $), with an average increase of 82.9% per quarter
NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 170.6% return, outperforming this stock by 148.1%

About Lexeo Therapeutics

Lexeo Therapeutics, Inc. is a clinical-stage genetic medicine company dedicated to transforming healthcare by applying pioneering science to fundamentally change how genetically defined cardiovascular diseases and APOE4-associated Alzheimers disease are treated. Using a stepwise development approach, the Company is leveraging early proof-of-concept functional and biomarker data to advance a pipeline of cardiovascular and APOE4-associated Alzheimers disease programs. Its pipeline consists of candidates targeting patient populations. Its most advanced cardiovascular product candidate, LX2006 for the treatment of patients with Friedreichs ataxia (FA), cardiomyopathy, is being evaluated in SUNRISE-FA, an ongoing Phase I/II clinical trial. Its second most advanced cardiovascular product candidate, LX2020 for the treatment of arrhythmogenic cardiomyopathy, caused by mutations in the PKP2 gene (PKP2-ACM), received IND clearance from the United States Food and Drug Administration (FDA).

Organisation	Lexeo Therapeutics
Headquarters	345 Park Avenue South, New York, NY, United States, 10010
CEO	Mr. R. Nolan Townsend
E-voting on shares	Click here to vote

Key Management of Lexeo Therapeutics

Name	Title
Dr. Jose Manuel Otero Ph.D.	Chief Technical Officer
Mr. Louis Tamayo	CFO & Principal Accounting Officer
Ms. Leslie DiRisio	Senior Vice President of Development Operations
Mr. Ryan McHenry	VP & Corporate Controller
Mr. R. Nolan Townsend	CEO & Director
Dr. Eric Adler M.D.	Chief Medical Officer & Head of Research
Dr. Ronald G. Crystal M.D.	Co-Founder, Chief Scientific Advisor & Member of Scientific Advisory Board
Ms. Jenny R. Robertson J.D.	Chief Legal Officer
Mr. Jordan M. Baumhardt Ph.D.	Vice President of Corporate Development
Dr. Sandi See Tai M.D.	Chief Development Officer

FAQs

What is Lexeo Therapeutics share price today?

Lexeo Therapeutics share price today is $9.46 as on December 9, 2025 at 1:37 am IST. Lexeo Therapeutics share today touched a day high of $9.71 and a low of $9.25.

What is the 52 week high and 52 week low for Lexeo Therapeutics share?

Lexeo Therapeutics share touched a 52 week high of $10.38 on October 29, 2025 and a 52 week low of $1.45 on April 7, 2025. Lexeo Therapeutics stock price today i.e. December 9, 2025 at 1:37 am IST is trending at $9.46,which is 8.86% down from its 52 week high and 552.41% up from its 52 week low.

What is Lexeo Therapeutics's market capitalisation today?

Lexeo Therapeutics market capitalisation is $0.00T as on December 9, 2025 at 1:37 am IST.

How to invest in Lexeo Therapeutics Stock (LXEO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Lexeo Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lexeo Therapeutics Shares that will get you 0.1586 shares as per Lexeo Therapeutics share price of $9.46 per share as on December 9, 2025 at 1:37 am IST.

What is the minimum amount required to buy Lexeo Therapeutics Stock (LXEO) from India?

Indian investors can start investing in Lexeo Therapeutics (LXEO) shares with as little as ₹90.066 or $1 (as of December 9, 2025 at 1:38 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹900.66 in Lexeo Therapeutics stock (as per the Rupee-Dollar exchange rate as on December 9, 2025 at 1:38 am IST). Based on Lexeo Therapeutics share’s latest price of $9.46 as on December 9, 2025 at 1:37 am IST, you will get 1.0571 shares of Lexeo Therapeutics. Learn more about fractional shares .